Information Provided By:
Fly News Breaks for June 15, 2015
BLUE
Jun 15, 2015 | 07:39 EDT
SunTrust believes that the data presented for bluebird's LentiGlobin was positive, since the total anti-sickling hemoglobin of the SCD patient being treated with the product increased significantly, while the patient's overall condition has improved, according to the firm. The firm keeps a Buy rating on the shares.